.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Medtronic
Harvard Business School
UBS
Accenture
Dow
Daiichi Sankyo
US Army
Chinese Patent Office
Cerilliant

Generated: June 24, 2017

DrugPatentWatch Database Preview

ETODOLAC Drug Profile

« Back to Dashboard

Which patents cover Etodolac, and what generic Etodolac alternatives are available?

Etodolac is a drug marketed by Sandoz, Apotex Inc, Mylan Pharms Inc, Teva, Mylan, Apotex, Oxford Pharms, Ani Pharms Inc, Ranbaxy Labs Ltd, Eci Pharms Llc, Watson Labs Florida, Zydus Pharms Usa Inc, Idt Australia Ltd, Chartwell Molecules, Watson Labs, Taro, Taro Pharm Inds, Ivax Sub Teva Pharms, and Actavis Elizabeth. and is included in thirty-three NDAs.

The generic ingredient in ETODOLAC is etodolac. There are twenty-two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the etodolac profile page.

Summary for Tradename: ETODOLAC

Patents:0
Applicants:19
NDAs:33
Suppliers / Packagers: see list37
Bulk Api Vendors: see list56
Clinical Trials: see list25
Patent Applications: see list8,631
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ETODOLAC at DailyMed

Pharmacology for Tradename: ETODOLAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
ETODOLAC
etodolac
TABLET;ORAL074846-001Feb 28, 1997DISCNNoNo► Subscribe► Subscribe
Chartwell Molecules
ETODOLAC
etodolac
CAPSULE;ORAL074842-001Jul 17, 1997DISCNNoNo► Subscribe► Subscribe
Mylan
ETODOLAC
etodolac
CAPSULE;ORAL075071-002Sep 30, 1998DISCNNoNo► Subscribe► Subscribe
Watson Labs
ETODOLAC
etodolac
TABLET;ORAL074892-002Oct 29, 1998DISCNNoNo► Subscribe► Subscribe
Teva
ETODOLAC
etodolac
TABLET, EXTENDED RELEASE;ORAL075665-002Jul 31, 2000ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Deloitte
Chinese Patent Office
US Army
Federal Trade Commission
Teva
Baxter
Johnson and Johnson
Cipla
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot